Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FN1E2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,579
Award facts
- Contract value 100% obligated
- $35,579.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $35,579.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Zepbound 15 mg/0.5 mL pens with an ultimate completion date of January 29, 2026. This is a non-set-aside competitive award with performance at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical through December 31, 2031, serving as the primary vehicle for pharmaceutical and medical supply deliveries to military healthcare programs globally.
This award is part of the DLA's medical supply chain operations supporting military treatment facilities and veterans' healthcare systems. Cencora, Inc., operating as AmerisourceBergen, is a leading pharmaceutical distributor that competes on a full and open basis for federal contracts and maintains significant market presence in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The narrow timeframe between award and completion dates reflects the expedited nature of this particular delivery order for the diabetes medication Zepbound.
Quick answers
Who was awarded contract SPE2DR26FN1E2?
SPE2DR26FN1E2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FN1E2 worth?
The government has obligated $35,579 on SPE2DR26FN1E2.
Is contract SPE2DR26FN1E2 an order under another contract?
Yes. SPE2DR26FN1E2 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FN1E2 competed?
The extent of competition for SPE2DR26FN1E2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award